Other peptides like CJC-1295 or AOD-9604 are marketed for fat loss, but unlike GLP-1 drugs, they lack robust human data and are not FDA-approved for obesity (FDA warning on unapproved peptides)
Heallys streamlined telehealth platform puts you in touch with licensed physicians who specialize in peptide therapy all from the comfort of your home
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials
Laboratory Grade Designed for researchers studying metabolic and endocrine pathways
This soap is designed for skin lightening and brightening, and contains kojic acid, L-glutathione, and alpha-arbutin
Standard maintenance therapy for pernicious anaemia involves injections every 2 to 3 months following an initial loading phase of six injections over two weeks